Calretinin

Type:

Definition:
Calretinin is a calcium-binding protein that is often used as a biomarker in pathology to help identify certain types of cells, particularly in diagnosing mesothelioma, a cancer strongly associated with asbestos exposure.

Phonetic Pronunciation:
(Kal-reh-TIN-in)

Etymological Origin:
The term "calretinin" is derived from "calcium," referring to its role in calcium binding, and "retinin," which relates to its initial discovery in the retina. It was first identified in the late 20th century as part of research into calcium-binding proteins.

Significance in Asbestos Context:
Calretinin is significant in the field of asbestos because it is a key immunohistochemical marker used to differentiate mesothelioma from other cancers, such as lung adenocarcinoma. Since mesothelioma is a primary disease caused by asbestos exposure, calretinin plays a crucial role in confirming diagnoses, which can impact treatment decisions and legal cases involving asbestos-related diseases.

Synonyms or Related Terms:

  • Immunohistochemical marker
  • Mesothelioma biomarker
  • Calcium-binding protein

Example Sentence:
"Pathologists often test for calretinin to confirm a diagnosis of mesothelioma in patients with a history of asbestos exposure."

Common Misconceptions:

  • Misconception: Calretinin is specific only to mesothelioma.
    Clarification: While calretinin is a reliable marker for mesothelioma, it is also expressed in other tissues and cancers, so it must be used alongside other markers for accurate diagnosis.
  • Misconception: Calretinin testing alone is sufficient for diagnosing mesothelioma.
    Clarification: A combination of markers, including calretinin, is typically used to ensure diagnostic accuracy.